Skip to main content
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
70.26
+1.04 (1.50%)
At close: Apr 28, 2026, 4:00 PM EDT
71.25
+0.99 (1.41%)
Pre-market: Apr 29, 2026, 7:13 AM EDT

PTC Therapeutics Revenue

In the year 2025, PTC Therapeutics had annual revenue of $1.73B with 114.51% growth. PTC Therapeutics had revenue of $164.68M in the quarter ending December 31, 2025, a decrease of -22.75%.

Revenue (ttm)
$1.73B
Revenue Growth
+114.51%
P/S Ratio
3.37
Revenue / Employee
$1,746,372
Employees
991
Market Cap
5.83B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.73B923.88M114.51%
Dec 31, 2024806.78M-131.04M-13.97%
Dec 31, 2023937.82M239.02M34.20%
Dec 31, 2022698.80M160.21M29.75%
Dec 31, 2021538.59M157.83M41.45%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Apellis Pharmaceuticals 1.00B
Caris Life Sciences 812.03M
Mirum Pharmaceuticals 521.31M
Rhythm Pharmaceuticals 189.76M
Centessa Pharmaceuticals 15.00M
CG Oncology 4.04M
Revenue Rankings

PTCT News

More News